The national drug regulator said that it has accepted the recommendation of the SEC “after careful examination” and accorded permission to Covaxin manufacturer Bharat Biotech.
DCGI approves Covaxin clinical trials for children aged 2-18 years - The trial will involve two vaccine doses injected on Day 1 and Day 28. This is the first time in India that a COVID vaccine will be tested on children
Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers
India News: NEW DELHI: Amid multiple states reporting a shortage of Covid-19 vaccine, Serum Institute and Bharat Biotech have submitted to the Centre their produc.
Wait 12-16 weeks to take second Covishield shot, govt panel recommends
The immunisation panel has recommended increasing the gap between two doses of Covishield vaccine to 12-16 weeks. No change in dosage interval for Covaxin has been suggested by the panel.
advertisement
UPDATED: May 13, 2021 12:48 IST
People wait outside a vaccination centre to receive a dose of Covid-19 vaccine, in Thane, May 12, 2021. (PTI Photo)
Increase the gap between two doses of Serum Institute of India s Oxford Covid-19 vaccine Covishield to 12-16 weeks, a government panel has recommended. Currently, the interval between two doses of Covishield is four to eight weeks.
No change in dosage interval for Covaxin was suggested by the panel.